Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02003924
What this trial is testing

Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Who this might be right for
Nonmetastatic Castration-Resistant Prostate CancerProstate CancerCancer of the Prostate
Pfizer 1,401
Post-approval studies (Phase 4)Study completedNCT02102646
What this trial is testing

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Who this might be right for
Prostate CancerMetabolic SyndromeHypogonadism+1 more
Herlev Hospital 31
Testing effectiveness (Phase 2)Ended earlyNCT02379390
What this trial is testing

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Who this might be right for
Prostate Cancer Metastatic
Sanofi 8
Early research (Phase 1)Study completedNCT02747342
What this trial is testing

Trial of SHR3680 With or Without SHR3162 in Prostate Cancer

Who this might be right for
NeoplasmProstate Cancer
Atridia Pty Ltd. 33
Not applicableStudy completedNCT02813226
What this trial is testing

Assessment of New Molecular Imaging Strategies for Prostate Cancer

Who this might be right for
Prostate Cancer
Ontario Clinical Oncology Group (OCOG) 36
Post-approval studies (Phase 4)Study completedNCT02918968
What this trial is testing

Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Astellas Pharma Inc 206
Not applicableLooking for participantsNCT07691697
What this trial is testing

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

Who this might be right for
Oligoprogressive Prostate CancerMetastatic Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Early research (Phase 1)Study completedNCT03724747
What this trial is testing

Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Bayer 63
Very early researchUnknownNCT03692663
What this trial is testing

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Allife Medical Science and Technology Co., Ltd. 9
Not applicableUnknownNCT03089099
What this trial is testing

Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Fudan University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05888532
What this trial is testing

64Cu-GRIP B in Patients With Advanced Malignancies

Who this might be right for
Prostate CancerRenal CancerUrethral Cancer+3 more
Rahul Aggarwal 91
Testing effectiveness (Phase 2)Ended earlyNCT04754425
What this trial is testing

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaCastration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted AgentsMetastatic Malignant Neoplasm in the Bone+5 more
M.D. Anderson Cancer Center 11
Post-approval studies (Phase 4)Looking for participantsNCT05348876
What this trial is testing

Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

Who this might be right for
Non-metastatic Castration-resistant Prostate Cancer
Bayer 50
Testing effectiveness (Phase 2)Study completedNCT02867852
What this trial is testing

Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers

Who this might be right for
Salivary Glands Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 24
Very early researchLooking for participantsNCT07798778
What this trial is testing

Clinical Evaluation of SRT-017 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Affiliated Hospital of Jiangnan University 18
Testing effectiveness (Phase 2)Ended earlyNCT04616547
What this trial is testing

Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Adenocarcinoma+3 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT03448458
What this trial is testing

Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v7
Emory University 17
Large-scale testing (Phase 3)Ended earlyNCT01522443
What this trial is testing

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration Resistant Prostate CancerPain+1 more
Exelixis 119
Not applicableStudy completedNCT03017417
What this trial is testing

A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-ResistantProstate Cancer
Sheffield Teaching Hospitals NHS Foundation Trust 31
Post-approval studies (Phase 4)Ended earlyNCT02441517
What this trial is testing

Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Global Development, Inc. 4
Next Page